Healthcare / Health Information ServicesUpdated 2026-05-10 22:07 UTC

TSXV/NURS stock hub

TSXV/NURS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TSXV/NURSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

219M

TSX Venture Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TSXV/NURS

In the news

Latest news · TSXV/NURS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E13.7

P25 11P50 15.6P75 25.4

Trailing P/E109.7

P25 7.4P50 15.6P75 34.3

ROE18.9

P25 -121.5P50 -40.9P75 0.5

ROIC6.3

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TSXV/NURS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

176

Groups with data

Currency

CAD

Showing 176 of 176 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 212.2M
Exchange	TSX Venture Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Health Information Services
Last refreshed	2026-05-10
Market cap	CAD 219M
Price	CAD 4.1
Price currency	CAD
Sector	Healthcare
Sic	8000
Symbol	tsxv/NURS
Website	https://hydreight.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.77%
EV Earnings	125.22x
EV/EBIT	151.78x
EV/EBITDA	114.64x
EV/FCF	-113.5x
EV/Sales	6x
FCF yield	-0.85%
Forward P/E	13.67x
P/B ratio	11.12x
P/E ratio	109.71x
P/S ratio	6.19x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	3.94%
EBITDA Margin	5.22%
Gross margin	25.44%
Gross Profit	CAD 9M
Gross Profit Growth	58.05%
Gross Profit Growth Q	136.03%
Gross Profit Growth3 Y	69.91%
Net Income	CAD 1.7M
Net Income Growth Q	6,031.34%
Pretax Margin	3.15%
Profit Margin	4.79%
ROA	4.73
Roa5y	-49.09
ROCE	4.89
ROE	18.9
ROIC	6.33

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	117.05%
Cagr3y	87.67%
Cagr5y	51.29%
Revenue Growth	120.54x
Revenue Growth Q	269.97x
Revenue Growth3 Y	102.39x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 1.92
Assets	CAD 33.8M
Cash	CAD 15.6M
Current Assets	CAD 20.9M
Current Liabilities	CAD 5.3M
Debt	CAD 8.8M
Debt EBITDA	CAD 4.75
Debt Equity	CAD 0.45
Debt FCF	CAD -4.69
Equity	CAD 19.7M
Interest Coverage	2.38
Liabilities	CAD 14.1M
Long Term Assets	CAD 12.8M
Long Term Liabilities	CAD 8.8M
Net Cash	CAD 6.9M
Net Cash By Market Cap	CAD 3.14
Net Cash Growth	1,849.09%
Net Debt EBITDA	CAD -3.72
Net Debt Equity	CAD -0.35
Tangible Book Value	CAD 17.2M
Tangible Book Value Per Share	CAD 0.36
WACC	8.09

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.98
Net Working Capital	CAD 37,310
Quick ratio	3.3
Working Capital	CAD 15.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-19.71%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	116.93%
200-day SMA	3.81
3Y total return	561.29%
50-day SMA	3.25
50-day SMA vs 200-day SMA	50under200
5Y total return	692.36%
All Time High	5.59
All Time High Change	-26.65%
All Time High Date	2025-11-10
All Time Low	0.2
All Time Low Change	1,950%
All Time Low Date	2024-04-15
ATR	0.33
Beta	0.72
Beta1y	0.71
Beta2y	1.01
Ch YTD	-13.32
High	4.3
High52	5.59
High52 Date	2025-11-10
High52ch	-26.65%
Low	3.95
Low52	1.46
Low52 Date	2025-06-23
Low52ch	180.82%
Ma50ch	26.04%
Price vs 200-day SMA	7.5%
RSI	59.61
RSI Monthly	60.44
RSI Weekly	56.01
Sharpe ratio	1.22x
Sortino ratio	2.11
Total Return	-19.71%
Tr YTD	-13.32
Tr1m	31.41%
Tr1w	5.13%
Tr3m	5.94%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD 1.4M
Operating Income Growth Q	12,600.2
Operating margin	3.94

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	27,089,013%
Net Borrowing	10,123,080
Shares Insiders	1.89%
Shares Institutions	1.07%
Shares Out	53,423,930
Shares Qo Q	8.68%
Shares Yo Y	19.71%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD -2M
Average Volume	144,451.95x
Bv Per Share	0.41
CAPEX	CAD -2,902
Ch1m	31.41
Ch1w	5.13
Ch1y	116.9
Ch3m	5.94
Ch3y	561.3
Ch5y	692.4
Ch6m	-17.17
Change	3.27%
Change From Open	2.5
Close	3.97
Days Gap	0.76
Depreciation Amortization	452,772
Dollar Volume	421,135.6
Earnings Date	2026-05-01
EBIT	CAD 1.4M
EBITDA	CAD 1.8M
EPS	CAD 0.04
F Score	2
FCF	CAD -1.9M
FCF EV Yield	-0.88x
FCF Per Share	CAD -0.03
Financing CF	18,002,543
Fiscal Year End	December
Graham Number	0.58628
Graham Upside	-85.7
Income Tax	CAD -580,337
Investing CF	-1,679,041
Is Primary Listing	1
Last Earnings Date	2025-11-21
Last Report Date	2025-12-31
Last Split Date	2022-11-25
Last Split Type	Reverse
Ma150	3.95
Ma150ch	3.69%
Ma20	3.96
Ma20ch	3.61%
Net CF	14,462,290
Open	4
Position In Range	42.86
Ppne	2,686
Price Date	2026-05-08
Price EBITDA	CAD 119
Ptbv Ratio	12.76
Relative Volume	0.71x
Revenue	35,385,038x
SBC By Revenue	0.23x
Share Based Comp	82,385
Tax By Revenue	-1.64x
Tr6m	-17.17%
Volume	102,716

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TSXV/NURS pay a dividend?

Capital-return profile for this ticker.

Performance

TSXV/NURS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TSXV/NURS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.1%

Share of float held by funds and institutions

Insider ownership

+1.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+19.7%

Negative means the company is buying back shares.

Technical

TSXV/NURS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

59.6

Neutral momentum band

Price vs 200-day MA

+7.5%

50/200-day relationship not available

Beta (5Y)

0.72

Less volatile than the market

Sharpe ratio

1.22

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TSXV/NURS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsxv/NURS stock rating?

tsxv/NURS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsxv/NURS analysis?

The full report lives at /stocks/tsxv/NURS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsxv/NURS?

The latest report frames tsxv/NURS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsxv/NURS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.